- Report
- March 2025
- 260 Pages
Middle East
From €2589EUR$2,900USD£2,265GBP
- Report
- March 2025
- 260 Pages
Africa
From €2589EUR$2,900USD£2,265GBP
- Report
- March 2025
- 210 Pages
Latin America
From €2589EUR$2,900USD£2,265GBP
- Report
- March 2025
- 840 Pages
Asia Pacific
From €2589EUR$2,900USD£2,265GBP
- Report
- March 2025
- 980 Pages
Europe
From €2589EUR$2,900USD£2,265GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3526EUR$3,950USD£3,085GBP
- Report
- June 2025
- 81 Pages
Africa, Middle East
From €3080EUR$3,450USD£2,695GBP
- Report
- June 2025
- 100 Pages
Europe
From €3526EUR$3,950USD£3,085GBP
- Report
- June 2025
- 89 Pages
North America
From €3080EUR$3,450USD£2,695GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €2892EUR$3,240USD£2,531GBP
€3214EUR$3,600USD£2,812GBP
- Report
- August 2021
- 50 Pages
United States
From €1928EUR$2,160USD£1,687GBP
€2143EUR$2,400USD£1,875GBP
- Report
- February 2024
- 158 Pages
Global
From €4151EUR$4,650USD£3,632GBP
- Report
- August 2023
- 336 Pages
Global
From €4151EUR$4,650USD£3,632GBP
- Report
- January 2023
- 127 Pages
Global
From €2009EUR$2,250USD£1,757GBP
- Report
- August 2024
- 120 Pages
Russia
From €5312EUR$5,950USD£4,647GBP
- Report
- November 2023
- 180 Pages
Global
From €5312EUR$5,950USD£4,647GBP
- Report
- September 2023
- 110 Pages
Global
From €5312EUR$5,950USD£4,647GBP
- Report
- November 2024
- 70 Pages
Australia
From €2223EUR$2,490USD£1,945GBP
- Report
- July 2023
- 220 Pages
Global
From €1777EUR$1,990USD£1,554GBP
- Report
- January 2023
- 180 Pages
Netherlands
From €2223EUR$2,490USD£1,945GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more